Search

Copyright of Chinese Journal of Diabetes Mellitus is the property of Chinese Journal of Diabetes Mellitus and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Copyright of Chinese Journal of Diabetes Mellitus is the property of Chinese Journal of Diabetes Mellitus and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Copyright of Chinese Journal of Diabetes Mellitus is the property of Chinese Journal of Diabetes Mellitus and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Copyright of Chinese Journal of Diabetes Mellitus is the property of Chinese Journal of Diabetes Mellitus and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

我国成人糖尿病前期（preDM）患病率仍在持续攀升, 目前preDM干预和管理面临诸多 困难和挑战。该文对preDM研究领域的国内外进展进行评述, 并着重对我国社区preDM管理模式和 综合管理体系建设进行讨论。. [ABSTRACT FROM AUTHOR]

Copyright of Chinese Journal of Diabetes Mellitus is the property of Chinese Journal of Diabetes Mellitus and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

】2型糖尿病(T2DM)的病理生理学机制复杂,基础胰岛素与胰高糖素样肽-l(GLP-l)受体 激动剂联合治疗可针对T2DM多重病理生理学缺陷，达到降糖作用机制互补，更好地发挥降糖作用。 德谷胰岛素-利拉鲁肽复方制剂(iDegLira)是长效基础胰岛素类似物和GLP-1受体激动剂的固定比例 复方制剂。多项临床研究结果显示,IDegLira是一种安全、有效的降糖治疗方案。笔者从该复方制剂 的互补作用机制、疗效、安全性等方面对其在临床治疗中的进展进行综述. [ABSTRACT FROM AUTHOR]

Copyright of Chinese Journal of Diabetes Mellitus is the property of Chinese Journal of Diabetes Mellitus and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

作为人体最大的内分泌器官，胃肠道在血糖稳态调控和糖尿病治疗中的作用日益凸显。 肠道产生的胰高糖素原衍生肽（PGDPs），即胰高糖素样肽‑1（GLP‑1）、GLP‑2、胃泌酸调节素、肠高血糖 素等，通过调控食物摄入、胃排空速率、胰岛素和胰高糖素释放等多条途径参与机体血糖稳态调节。 基于肠道PGDPs的药物能够纠正2型糖尿病发病机制中的多种病理生理缺陷，有效改善血糖，已成为 糖尿病领域的研究热点。. [ABSTRACT FROM AUTHOR]